CoChat

Discovery of bioactive microbial gene products in inflammatory bowel disease

Open access
Zhang, Yancong, Bhosle, Amrisha, Bae, Sena, McIver, Lauren J., Pishchany, Gleb, Accorsi, Emma K., Thompson, Kelsey N., Arze, Cesar, Wang, Ya, Subramanian, Ayshwarya, Kearney, Sean M., Pawluk, April, Plichta, Damian R., Rahnavard, Ali, Shafquat, Afrah, Xavier, Ramnik J., Vlamakis, Hera, Garrett, Wendy S., Krueger, Andy, Huttenhower, Curtis, Franzosa, Eric A. · 2022 · Nature
Cited by 100

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Microbial communities and their associated bioactive compounds1–3 are often disrupted in conditions such as the inflammatory bowel diseases (IBD)4. However, even in well-characterized environments (for example, the human gastrointestinal tract), more than one-third of microbial proteins are uncharacterized and often expected to be bioactive5–7. Here we systematically identified more than 340,000 protein families as potentially bioactive with respect to gut inflammation during IBD, about half of which have not to our knowledge been functionally characterized previously on the basis of homology or experiment. To validate prioritized microbial proteins, we used a combination of metagenomics, metatranscriptomics and metaproteomics to provide evidence of bioactivity for a subset of proteins that are involved in host and microbial cell–cell communication in the microbiome; for example, proteins associated with adherence or invasion processes, and extracellular von Willebrand-like factors. Predictions from high-throughput data were validated using targeted experiments that revealed the differential immunogenicity of prioritized Enterobacteriaceae pilins and the contribution of homologues of von Willebrand factors to the formation of Bacteroides biofilms in a manner dependent on mucin levels. This methodology, which we term MetaWIBELE (workflow to identify novel bioactive elements in the microbiome), is generalizable to other environmental communities and human phenotypes. The prioritized results provide thousands of candidate microbial proteins that are likely to interact with the host immune system in IBD, thus expanding our understanding of potentially bioactive gene products in chronic disease states and offering a rational compendium of possible therapeutic compounds and targets. A computational system termed MetaWIBELE (workflow to identify novel bioactive elements in the microbiome) is used to identify microbial gene products that are potentially bioactive and have a functional role in the pathogenesis of inflammatory bowel disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-022-04648-7

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 100

Metadata

Authors
Zhang, Y., Bhosle, A., Bae, S., McIver, L. J., Pishchany, G., Accorsi, E. K., Thompson, K. N., Arze, C., Wang, Y., Subramanian, A., Kearney, S. M., Pawluk, A., Plichta, D. R., Rahnavard, A., Shafquat, A., Xavier, R. J., Vlamakis, H., Garrett, W. S., Krueger, A., Huttenhower, C., & Franzosa, E. A.
Venue
Nature
Published
2022-05-25
Volume
606
Issue
7915
Pages
754-760
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4281487561
Cited by
100
References
17
FWCI
5.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of bioactive microbial gene products in inflammatory bowel disease. https://app.cochat.ai/papers/10.1038/s41586-022-04648-7
The paper
Zhang, Y., Bhosle, A., Bae, S., McIver, L. J., Pishchany, G., Accorsi, E. K., Thompson, K. N., Arze, C., Wang, Y., Subramanian, A., Kearney, S. M., Pawluk, A., Plichta, D. R., Rahnavard, A., Shafquat, A., Xavier, R. J., Vlamakis, H., Garrett, W. S., Krueger, A., . . . Franzosa, E. A. (2022). Discovery of bioactive microbial gene products in inflammatory bowel disease. Nature. https://doi.org/10.1038/s41586-022-04648-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.